BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8993014)

  • 1. The human complement C1 complex has a picomolar dissociation constant at room temperature.
    Tseng Y; Zavodszky P; Schumaker VN
    J Immunol; 1997 Jan; 158(2):937-44. PubMed ID: 8993014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subunit interactions in the first component of complement, C1.
    Lakatos S
    Biochem Biophys Res Commun; 1987 Dec; 149(2):378-84. PubMed ID: 2827640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.
    Ziccardi RJ
    J Immunol; 1982 Jun; 128(6):2500-4. PubMed ID: 6281332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
    Bianchino AC; Poon PH; Schumaker VN
    J Immunol; 1988 Dec; 141(11):3930-6. PubMed ID: 3183385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
    Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
    Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for the third constant domain of the IgG H chain in activation of complement in the presence of C1 inhibitor.
    Okada M; Utsumi S
    J Immunol; 1989 Jan; 142(1):195-201. PubMed ID: 2491872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-independent C1 activation by E. coli.
    Tenner AJ; Ziccardi RJ; Cooper NR
    J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G; van Es LA; Daha MR
    J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
    Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
    J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models for C1. Tools or toys? The real biological challenge.
    Colomb MG; Arlaud GJ; Chesne S
    Behring Inst Mitt; 1989 Jul; (84):121-8. PubMed ID: 2552979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of C1 and concentration dependence of its activation kinetics.
    Kilchherr E; Fuchs H; Tschopp J; Engel J
    Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stoichiometry and sedimentation properties of the complex formed between the C1q and C1r2C1s2 subcomponents of the first component of complement.
    Siegel RC; Schumaker VN; Poon PH
    J Immunol; 1981 Dec; 127(6):2447-52. PubMed ID: 6975324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models for the C1 complex determined by physical techniques.
    Perkins SJ
    Behring Inst Mitt; 1989 Jul; (84):129-41. PubMed ID: 2552980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure and function of the first component of complement: genetic engineering approach (a review).
    Gál P; Cseh S; Schumaker VN; Závodszky P
    Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron microscope studies of C1s, C1s2, C1r2, C1r2C1s2 and C1-inhibitor.
    Schumaker VN; Phillips ML
    Behring Inst Mitt; 1993 Dec; (93):17-24. PubMed ID: 8172564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.